Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
Outline of Final Research Achievements |
Various hemostatic markers were significantly increased or decreased. The cutoff value of D-dimer and SF were determined to diagnose or predict thrombosis. AT, PC or PS abnormalities were frequently diagnosed by genetic analysis in VTE patients and the polymorphism of Fibrinogen αchain were significantly higher in female infertility than in healthy pregnant women. In Kinki area, C3I1157T variant was detected in 14 cases of aHUS patients. Several carrier who had genetic variant, had no symptom. The diagnostic criteria established by Japanese Society of Thrombosis and Hemostasis using AT, TAT, SF and decreased platelet count was significantly more useful than other diagnostic criteria for diagnosing DIC or Pre-DIC.
|